yreprofylakse ved ST-segment elevation myokardie infarkt og primær PCI
Phase 1
- Conditions
- Decreased renal function in patients with STEMI undergoing acute PCI
- Registration Number
- EUCTR2009-017642-32-DK
- Lead Sponsor
- Odense University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
STEMI patients undergoing primary PCI
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Cardiogen shock or unconscious.
Ventricular fibbrillation or cardiac arrest.
Known maligncy or serious infection disease.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Change in se-creatinine day 0-3 following PCI;Secondary Objective: Change in se-creatinine day 3-30<br>Change in se-creatinine day 0-30;Primary end point(s): Change in se-ceatinine day 0-3
- Secondary Outcome Measures
Name Time Method